NCT03730571View on ClinicalTrials.gov

The AbsorbaSeal Vascular Closure Device Trial

NATerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 16, 2017

Primary Completion Date

April 11, 2019

Study Completion Date

April 11, 2019

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

AbsorbaSeal 6Fr Vascular Closure Device

Patients whose access site will be closed with the AbsorbaSeal 6Fr Vascular Closure Device

Trial Locations (3)

2820

Imelda Hospital, Bonheiden

9200

A.Z. Sint-Blasius, Dendermonde

9300

O.L.V. Hospital, Aalst

Sponsors

Lead Sponsor

ID3 Medical
All Listed Sponsors
collaborator

CyndRx, LLC

INDUSTRY

lead

ID3 Medical

OTHER

NCT03730571 - The AbsorbaSeal Vascular Closure Device Trial | Biotech Hunter | Biotech Hunter